SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001157523-11-006553
Filing Date
2011-11-07
Accepted
2011-11-07 17:01:17
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS, INC. 10-Q a50048699.htm 10-Q 848668
2 EXHIBIT 10.1 a50048699_ex101.htm EX-10.1 128630
3 EXHIBIT 31.1 a50048699_ex311.htm EX-31.1 15698
4 EXHIBIT 31.2 a50048699_ex312.htm EX-31.2 16126
5 EXHIBIT 32.1 a50048699_ex321.htm EX-32.1 8204
  Complete submission text file 0001157523-11-006553.txt   2975439

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aria-20110930.xml EX-101.INS 394551
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aria-20110930.xsd EX-101.SCH 13025
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aria-20110930_cal.xml EX-101.CAL 36714
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aria-20110930_def.xml EX-101.DEF 81196
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aria-20110930_lab.xml EX-101.LAB 86541
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aria-20110930_pre.xml EX-101.PRE 89093
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21696 | Film No.: 111185318
SIC: 2836 Biological Products, (No Diagnostic Substances)